[Current problems in the diagnosis and treatment of patients with myocarditis].

Authors:
Address:
Journal:


Publication:

abstract

myocarditis as inflammatory cardiomyopathy is considered to be the primary group acquired cardiomyopathy. It is a disease of diverse etiology, which involves inflammation cardiomyocytes, interstitial tissue, vessels and sometimes the pericardium. The prevalence is not accurately known. Myocarditis is caused by many etiological factors: viruses, bacteria, protozoa and parasites. The presence of eosinophilic myocarditis is related to chemical compounds, including many drugs. This disease, although known for a long time still poses many problems in everyday medical practice. Clinical course of the disease and frequent process of transition dilated cardiomyopathy, tends to isolate the three phases of the disease: viral, autoimmune and dilated cardiomyopathy. These phases arise from the close link between viral infection and the accompanying immune response (especially contagious infection). In fact, the secondary immune response leads to activation of cytotoxic cells (CD8), which gives rise to antibodies directed against cardiomyocytes. diagnosis of this disease is difficult and expensive, uses methods: direct (culture), molecular (PCR, hybridization) and imaging methods (echocardiography, MRI). treatment of myocarditis depends on the phase and the etiology of the disease. In phase includes nonspecific viral antiviral agents, and avoidance of potentially harmful immunosuppression. The therapy is used among other immunoglobulins, statins, and patients in the phase dilated cardiomyopathy should be treated as idiopathic dilated cardiomyopathy and congestive heart failure. Myocarditis is one of the few units of cardiac disease for which there are no uniform standards of medical practice.



Related Articles
Review Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Herz. 2004
Review Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B, Hufnagel G, Kölsch S, Funck R, Richter A, Rupp H, Herzum M, Pankuweit S. Herz. 2004 Sep; 29(6):624-36.
Review Inflammatory dilated cardiomyopathy (DCMI).
Herz. 2005
Review Inflammatory dilated cardiomyopathy (DCMI).
Maisch B, Richter A, Sandmöller A, Portig I, Pankuweit S, BMBF-Heart Failure Network. Herz. 2005 Sep; 30(6):535-44.
Review Inflammation in dilated cardiomyopathy.
Herz. 2004
Review Inflammation in dilated cardiomyopathy.
Pankuweit S, Ruppert V, Maisch B. Herz. 2004 Dec; 29(8):788-93.
Review [Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].
Med Klin (Munich). 2005
Review [Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].
Kuhn H, Lawrenz T, Beer G. Med Klin (Munich). 2005 Sep 15; 100(9):553-61.
Review [Myocarditis and dilated cardiomyopathy in children. Old questions-- new answers].
Lijec Vjesn. 1999
Review [Myocarditis and dilated cardiomyopathy in children. Old questions-- new answers].
Malcić I, Buljević AD. Lijec Vjesn. 1999 Apr-May; 121(4-5):129-36.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.